Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice

por Casiraghi, Andrea, Longhena, Francesca, Faustini, Gaia, Ribaudo, Giovanni, Suigo, Lorenzo, Camacho-Hernandez, Gisela Andrea, Bono, Federica, Brembati, Viviana, Newman, Amy Hauck, Gianoncelli, Alessandra, Straniero, Valentina, Bellucci, Arianna, Valoti, Ermanno
Publicado 2022

Phosphatidylinositol 4,5-bisphosphate (PIP(2)) facilitates norepinephrine transporter dimerization and modulates substrate efflux

por Luethi, Dino, Maier, Julian, Rudin, Deborah, Szöllősi, Dániel, Angenoorth, Thomas J. F., Stankovic, Stevan, Schittmayer, Matthias, Burger, Isabella, Yang, Jae-Won, Jaentsch, Kathrin, Holy, Marion, Das, Anand Kant, Brameshuber, Mario, Camacho-Hernandez, Gisela Andrea, Casiraghi, Andrea, Newman, Amy Hauck, Kudlacek, Oliver, Birner-Gruenberger, Ruth, Stockner, Thomas, Schütz, Gerhard J., Sitte, Harald H.
Publicado 2022